Oraverse recalls
Oraverse products have been recalled 2 times, most recently on 24 Dec 2025. The recalling company is usually Septodont. The most common reason is packaging defects.
Total recalls2since 2018
Last 12 months1reported
Class I00% of total
Ongoing1latest 24 Dec 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why oraverse is recalled
Companies
Product types
By year
Ongoing oraverse recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | OraVerse, (Phentolamine Mesylate) Injection, 4 mg recalledOraverse | Novocol Pharmaceutical of Canada | Packaging Defects | Nationwide |
All oraverse recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | OraVerse, (Phentolamine Mesylate) Injection, 4 mg recalledOraverse | Novocol Pharmaceutical of Canada | Packaging Defects | Nationwide |
| Drug | CLASS III | OraVerse (Phentolamine Mesylate) Injection, 4 mg recalled by SeptodontOraverse | Septodont | Potency & Assay | CO |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.